Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, December 20th.
According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “
A number of other research firms also recently commented on RBGLY. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Reckitt Benckiser Group in a research report on Monday, December 18th. BNP Paribas reaffirmed a “neutral” rating on shares of Reckitt Benckiser Group in a research report on Tuesday, September 5th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. Reckitt Benckiser Group presently has an average rating of “Hold” and a consensus target price of $21.00.
Shares of Reckitt Benckiser Group (OTCMKTS:RBGLY) traded up $0.07 on Wednesday, hitting $18.75. 411,444 shares of the company traded hands, compared to its average volume of 866,784. The company has a quick ratio of 0.67, a current ratio of 0.86 and a debt-to-equity ratio of 1.94. Reckitt Benckiser Group has a 12 month low of $16.47 and a 12 month high of $21.55.
WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/01/11/reckitt-benckiser-group-rbgly-upgraded-by-zacks-investment-research-to-hold.html.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Get a free copy of the Zacks research report on Reckitt Benckiser Group (RBGLY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.